On Nov 05, major Wall Street analysts update their ratings for $Eastman Chemical (EMN.US)$, with price targets ranging from $110 to $130.
BofA Securities analyst Salvator Tiano maintains with a hold rating, and adjusts the target price from $119 to $115.
Barclays analyst Michael Leithead maintains with a hold rating, and maintains the target price at $111.
Deutsche Bank analyst David Begleiter maintains with a hold rating, and adjusts the target price from $108 to $110.
Wells Fargo analyst Michael Sison maintains with a hold rating, and adjusts the target price from $118 to $110.
Jefferies analyst Laurence Alexander maintains with a buy rating, and maintains the target price at $130.
Furthermore, according to the comprehensive report, the opinions of $Eastman Chemical (EMN.US)$'s main analysts recently are as follows:
The 'base' business of Eastman Chemical is performing largely better than anticipated, even in the face of a challenging environment looking ahead. However, the ramp-up of the Kingsport methanolysis is encountering further complications. The current valuation of the shares is considered fair when focusing on the base business, with the majority of the potential upside being contingent upon the successful implementation of its methanolysis technology at more locations.
The firm maintains an Equal Weight rating on Eastman Chemical's shares, acknowledging the potential for double-digit EPS growth by 2025. This anticipated growth is considered to be already incorporated into the current valuation. Further insights are anticipated from Eastman's Kingsport tour scheduled for November, which will likely provide more details on the upside potential of the company's circular strategy.
Here are the latest investment ratings and price targets for $Eastman Chemical (EMN.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間11月5日，多家華爾街大行更新了$伊士曼化工 (EMN.US)$的評級，目標價介於110美元至130美元。
美銀證券分析師Salvator Tiano維持持有評級，並將目標價從119美元下調至115美元。
巴克萊銀行分析師Michael Leithead維持持有評級，維持目標價111美元。
德意志銀行分析師David Begleiter維持持有評級，並將目標價從108美元上調至110美元。
富國集團分析師Michael Sison維持持有評級，並將目標價從118美元下調至110美元。
富瑞集團分析師Laurence Alexander維持買入評級，維持目標價130美元。
此外，綜合報道，$伊士曼化工 (EMN.US)$近期主要分析師觀點如下：
伊士曼化工的「基礎」業務表現比預期要好得多，即便在前景充滿挑戰的環境下也是如此。然而，金斯波特甲醇解聚的升級過程遇到了進一步的複雜情況。目前的股票估值在着眼於基礎業務時被認爲是公平的，大部分潛在增長的上行空間取決於其在更多地點成功實施甲醇解聚技術。
該公司維持對伊士曼化工股票的等權評級，認識到到2025年可能會出現兩位數的每股收益增長。這種預期的增長被認爲已經融入到了當前的估值中。東曼計劃於11月舉行金斯波特之行，進一步的見解預計將提供更多關於公司圓循環策略潛力的細節。
以下爲今日6位分析師對$伊士曼化工 (EMN.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
